Brief: Xbrane Biopharma Q4 Revenue Down At Sek 9.1 Million

Xbrane Biopharma AB

20/02/2026 07:11

Feb 20 (Reuters) - Xbrane Biopharma AB XBRANE.ST:

Q4 REVENUE SEK 9.1 MILLION

Q4 EBITDA SEK -21.9 MILLION

Q4 EPS SEK -0.06

Q4 NET INCOME SEK -26.5 MILLION

DIVIDEND PROPOSAL: NO DIVIDEND

Source text: ID:nMFN7cwQw9

Further company coverage: XBRANE.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))